J Koirala

Summary

Affiliation: Southern Illinois University School of Medicine
Country: USA

Publications

  1. ncbi Distribution of antibody titer against Salmonella enterica among healthy individuals in nepal
    Bharat M Pokhrel
    Tribhuvan University, Institute of Medicine, Department of Microbiology, Maharajgunj, Kathmandu, Nepal
    Ann Clin Microbiol Antimicrob 8:1. 2009
  2. ncbi Plague: disease, management, and recognition of act of terrorism
    Janak Koirala
    Division of Infectious Diseases, Department of Internal Medicine, Southern Illinois University School of Medicine, 751 North Rutledge, Room 1100, Springfield, IL 62702, USA
    Infect Dis Clin North Am 20:273-87, viii. 2006
  3. ncbi Granulocyte colony-stimulating factor dosing in pegylated interferon alpha-induced neutropenia and its impact on outcome of anti-HCV therapy
    J Koirala
    Division of Infectious Diseases, Department of Medicine, School of Medicine, Southern Illinois University, Springfield, IL 62794 9636, USA
    J Viral Hepat 14:782-7. 2007
  4. ncbi Interferon-gamma receptors in HIV-1 infection
    Janak Koirala
    Division of Infectious Diseases, Southern Illinois University, School of Medicine, Springfield, Illinois 62794 9636, USA
    AIDS Res Hum Retroviruses 24:1097-102. 2008
  5. ncbi Infections in diabetes mellitus and hyperglycemia
    Smita Gupta
    Division of Endocrinology, Metabolism and Molecular Medicine, Southern Illinois University School of Medicine, 701 North First Street, D 405B, PO Box 19636, Springfield, IL 62794 9636, USA
    Infect Dis Clin North Am 21:617-38, vii. 2007
  6. ncbi Initial antiretroviral therapy in chronically-infected HIV-positive adults
    Zelalem Temesgen
    Mayo Clinic and Foundation, Division of Infectious Diseases, Rochester, MN 55905, USA
    Expert Opin Pharmacother 5:595-612. 2004
  7. ncbi Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection
    Gerd Fatkenheuer
    Universitätsklinik Köln, Cologne, Germany
    N Engl J Med 359:1442-55. 2008
  8. ncbi Maraviroc for previously treated patients with R5 HIV-1 infection
    Roy M Gulick
    Weill Cornell Medical College, New York, NY 10065, USA
    N Engl J Med 359:1429-41. 2008
  9. ncbi Famciclovir substitution for patients with acyclovir-associated renal toxicity
    Tin Han Htwe
    Division of Infectious Diseases, Department of Medicine, Southern Illinois University School of Medicine, Springfield, P O Box 19636, IL 62794 9636, USA
    J Infect 57:266-8. 2008
  10. ncbi Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations
    Scott J Bergman
    Department of Pharmacy Practice, Southern Illinois University Edwardsville School of Pharmacy, Edwardsville, IL, USA
    Infect Dis Clin North Am 21:821-46, x. 2007

Collaborators

Detail Information

Publications13

  1. ncbi Distribution of antibody titer against Salmonella enterica among healthy individuals in nepal
    Bharat M Pokhrel
    Tribhuvan University, Institute of Medicine, Department of Microbiology, Maharajgunj, Kathmandu, Nepal
    Ann Clin Microbiol Antimicrob 8:1. 2009
    ..Enteric fever is an endemic problem in Nepal and Widal agglutination test is widely used for its diagnosis but a normal baseline titer in healthy population and cutoff values have not been established...
  2. ncbi Plague: disease, management, and recognition of act of terrorism
    Janak Koirala
    Division of Infectious Diseases, Department of Internal Medicine, Southern Illinois University School of Medicine, 751 North Rutledge, Room 1100, Springfield, IL 62702, USA
    Infect Dis Clin North Am 20:273-87, viii. 2006
  3. ncbi Granulocyte colony-stimulating factor dosing in pegylated interferon alpha-induced neutropenia and its impact on outcome of anti-HCV therapy
    J Koirala
    Division of Infectious Diseases, Department of Medicine, School of Medicine, Southern Illinois University, Springfield, IL 62794 9636, USA
    J Viral Hepat 14:782-7. 2007
    ..Timing of G-CSF administration did not make any significant impact on the patient's neutrophil counts but was better tolerated when given 2 days apart from PEG-IFN-alpha...
  4. ncbi Interferon-gamma receptors in HIV-1 infection
    Janak Koirala
    Division of Infectious Diseases, Southern Illinois University, School of Medicine, Springfield, Illinois 62794 9636, USA
    AIDS Res Hum Retroviruses 24:1097-102. 2008
    ..This dysfunction in the interferon-gamma pathway contributes to a further impairment in cellular immune function in patients with advanced HIV-1 infection, which may further increase susceptibility to opportunistic infections...
  5. ncbi Infections in diabetes mellitus and hyperglycemia
    Smita Gupta
    Division of Endocrinology, Metabolism and Molecular Medicine, Southern Illinois University School of Medicine, 701 North First Street, D 405B, PO Box 19636, Springfield, IL 62794 9636, USA
    Infect Dis Clin North Am 21:617-38, vii. 2007
    ..Given the risks of not alleviating the metabolic dysregulation and the benefits of decent glycemic control, it is necessary that besides antimicrobial therapy, equal emphasis be placed on intensified glycemic control...
  6. ncbi Initial antiretroviral therapy in chronically-infected HIV-positive adults
    Zelalem Temesgen
    Mayo Clinic and Foundation, Division of Infectious Diseases, Rochester, MN 55905, USA
    Expert Opin Pharmacother 5:595-612. 2004
    ....
  7. ncbi Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection
    Gerd Fatkenheuer
    Universitätsklinik Köln, Cologne, Germany
    N Engl J Med 359:1442-55. 2008
    ....
  8. ncbi Maraviroc for previously treated patients with R5 HIV-1 infection
    Roy M Gulick
    Weill Cornell Medical College, New York, NY 10065, USA
    N Engl J Med 359:1429-41. 2008
    ..CC chemokine receptor 5 antagonists are a new class of antiretroviral agents...
  9. ncbi Famciclovir substitution for patients with acyclovir-associated renal toxicity
    Tin Han Htwe
    Division of Infectious Diseases, Department of Medicine, Southern Illinois University School of Medicine, Springfield, P O Box 19636, IL 62794 9636, USA
    J Infect 57:266-8. 2008
    ..All four patients subsequently had improvements in their symptoms with full recovery of their baseline renal function...
  10. ncbi Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations
    Scott J Bergman
    Department of Pharmacy Practice, Southern Illinois University Edwardsville School of Pharmacy, Edwardsville, IL, USA
    Infect Dis Clin North Am 21:821-46, x. 2007
    ..The populations described here include patients with obesity and diabetes mellitus, renal or hepatic failure, chronic lung disease, severe burns, and long-term prosthetic devices and the elderly...
  11. ncbi Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives
    Bharat M Pokharel
    Department of Microbiology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal
    Int J Infect Dis 10:434-8. 2006
    ..enterica serotype Paratyphi A with higher rates of multidrug resistance and ESBL production is concerning for natives as well as travelers in Nepal since the current typhoid vaccines do not provide protection against this serotype...
  12. ncbi Trimethoprim-sulfamethoxazole--induced methemoglobinemia in an HIV-infected patient
    Janak Koirala
    Mayo Clin Proc 79:829-30. 2004
  13. ncbi Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium
    Termkiat Kanchanapoom
    Southern Illinois University School of Medicine, Springfield, Illinois, USA
    Diagn Microbiol Infect Dis 45:213-5. 2003
    ..v. quinupristin/dalfopristin and i.v. linezolid. The patient deteriorated after receiving three dosages of intraventricular quinupristin/dalfopristin. He recovered after discontinuation of intraventricular quinupristin/dalfopristin...